沈陽(yáng)藥科大學(xué)制藥工程學(xué)院導(dǎo)師:劉丹

發(fā)布時(shí)間:2021-11-20 編輯:考研派小莉 推薦訪問(wèn):
沈陽(yáng)藥科大學(xué)制藥工程學(xué)院導(dǎo)師:劉丹

沈陽(yáng)藥科大學(xué)制藥工程學(xué)院導(dǎo)師:劉丹內(nèi)容如下,更多考研資訊請(qǐng)關(guān)注我們網(wǎng)站的更新!敬請(qǐng)收藏本站,或下載我們的考研派APP和考研派微信公眾號(hào)(里面有非常多的免費(fèi)考研資源可以領(lǐng)取,有各種考研問(wèn)題,也可直接加我們網(wǎng)站上的研究生學(xué)姐微信,全程免費(fèi)答疑,助各位考研一臂之力,爭(zhēng)取早日考上理想中的研究生院校。)

沈陽(yáng)藥科大學(xué)制藥工程學(xué)院導(dǎo)師:劉丹 正文

[導(dǎo)師姓名]
劉丹

[所屬院校]
沈陽(yáng)藥科大學(xué)

[基本信息]
導(dǎo)師姓名:劉丹
性別:女
人氣指數(shù):1453
所屬院校:沈陽(yáng)藥科大學(xué)
所屬院系:制藥工程學(xué)院
職稱:副教授
導(dǎo)師類型:碩導(dǎo)
招生專業(yè):藥物化學(xué)、藥學(xué)(藥物化學(xué)方向)
研究領(lǐng)域:一:靶向抗腫瘤藥物的設(shè)計(jì)與研究研究方向二:藥物合成新工藝的開(kāi)發(fā)研究方向三:納米前藥的設(shè)計(jì)與...

[通訊方式]
辦公電話:024-43520218
電子郵件:sammyld@163.com
通訊地址:遼寧省本溪高新技術(shù)產(chǎn)業(yè)開(kāi)發(fā)區(qū)華佗大街26號(hào)沈陽(yáng)藥科大學(xué)47號(hào)信箱

[個(gè)人簡(jiǎn)述]
劉丹,女,博士,副教授。2000年畢業(yè)于沈陽(yáng)藥科大學(xué),獲化學(xué)制藥學(xué)士學(xué)位,2000年考入沈陽(yáng)藥科大學(xué)藥物化學(xué)專業(yè)碩士研究生,2002年直接攻讀博士學(xué)位,2008年獲沈陽(yáng)藥科大學(xué)藥物化學(xué)博士學(xué)位,2009年進(jìn)入天津天士力集團(tuán)有限公司進(jìn)行博士后研究。2005年留校任教,2011年晉升副教授,碩士研究生導(dǎo)師,2012年赴美國(guó)北卡羅來(lái)納大學(xué)教堂山分校交流訪問(wèn),現(xiàn)為制藥工程學(xué)院藥物化學(xué)教研室主任。作為課題負(fù)責(zé)人主持了國(guó)家自然科學(xué)基金項(xiàng)目2項(xiàng),遼寧省科技廳項(xiàng)目2項(xiàng),沈陽(yáng)市科技廳項(xiàng)目1項(xiàng),沈陽(yáng)藥科大學(xué)科研專項(xiàng)基金2項(xiàng),另外,作為項(xiàng)目骨干成員參加國(guó)家科技部重大新藥創(chuàng)制項(xiàng)目5項(xiàng),科技部國(guó)際合作項(xiàng)目1項(xiàng),國(guó)家自然科學(xué)基金面上項(xiàng)目5項(xiàng)。目前已在Nano Letters、ACS Applied Materials & Interfaces、European Journal of Medicinal Chemistry、Bioorganic & Medicinal Chemistry、Scientific Reports等期刊發(fā)表學(xué)術(shù)論文30余篇。

[科研工作]
近年來(lái)發(fā)表代表性論文
1.Yang Jinyu, Cheng Gaoliang,Xu Qihao, Luan Shenglin, Wang Shuxiang, LiuDan*, Zhao Linxiang*. Design, synthesis and biological evaluation of novelhydroxamic acid based histone deacetylase 6 selective inhibitors bearingphenylpyrazol scaffold as surface recognition motif. Bioorganic & MedicinalChemistry, 2018, 26(8):1418-1425. (IF=2.486)2.Shenglin Luan, Hang Zhong,Xuan Zhao, Jinyu Yang, Yongkui Jing, DanLiu*, Linxiang Zhao*. Synthesis, anticancer evaluation and pharmacokineticstudy of novel 10-O-phenyl ethers of dihydroartemisinin. European Journal ofMedicinal Chemistry. 2017, 141: 584-595. (IF=4.519)3.XiangfeiHan, Jinling Chen, Mengjuan Jiang, Na Zhang, Kexin Na, Cong Luo, Ruoshi Zhang,Mengchi Sun, Guimei Lin, Rong Zhang, Yan Ma, Dan Liu*, and Yongjun Wang*, Paclitaxel?paclitaxel prodrug nanoassembly as a versatilenanoplatform for combinational cancer therapy. ACS Applied Materials &Interfaces. 2016, 8: 33506?33513. (IF=7.504)4.Kun Li, Lei Li,Shuxiang Wang, Xiaojing Li, Tianyi Ma, DanLiu*, Yongkui Jing*, Linxiang Zhao*, Design and synthesis of novel 2-substituted11-keto-boswellic acid heterocyclic derivatives as anti-prostate cancer agentswith Pin1 inhibition ability. European Journal of Medicinal Chemistry. 2016,126: 910-919. (IF=4.519)5.Yin-bo Fan, MinHuang, Yu Cao, Ping Gong, Wen-bing Liu, Shu-yu Jin, Jia-chen Wen, Yong-kuiJing, Dan Liu*, Lin-xiang Zhao*.Usnic acid is a novel Pim-1 inhibitor with the abilities of inhibiting growthand inducing apoptosis in human myeloid leukemia cells. RSC Advances,2016,6,24091-24096. (IF= 3.108)6.Jiachen Wen, Yu Bao, Qun Niu, Jinyu Yang, Yinbo Fan, Jinhua Li, YongkuiJing*, Linxiang Zhao*, Dan Liu*. Identification of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide and its disulfide prodrug as potenthistone deacetylase inhibitors with in vitro and in vivo anti-tumor efficacy.European Journal of Medicinal Chemistry, 2016, 109: 350-359. (IF=4.519)7.Hang Zhong, Xuan Zhao, Zhizhong Zuo, Jingwei Sun, Yao Yao, Tao Wang, Dan Liu*, Linxiang Zhao*. Combating P-glycoprotein-mediated multidrug resistancewith 10-O-phenyl dihydroartemisinin ethers in MCF-7 cells. European Journal ofMedicinal Chemistry. 2016, 108:720-729. (IF=4.519)8.Qiang Fu, YongjunWang*, Yan Ma, D. Zhang, J. K. Fallon, Xinggang Yang, Dan Liu*, Zhonggui He & Feng Liu. Programmed hydrolysis indesigning paclitaxel prodrug for nanocarrier assembly. Scientific Reports,2015, DOI: 10.1038/srep12023. (IF 5.228)9.Yongjun Wang*?, Dan Liu?, QingchuanZheng, Qiang Zhao, Hongjuan Zhang, Yan Ma, John K. Fallon, Qiang Fu, Matthew T.Haynes, Guimei Lin, Rong Zhang, Dun Wang, Xinggang Yang, Linxiang Zhao,Zhonggui He,* and Feng Liu, Disulfide bond bridge insertion turns hydrophobicanticancer prodrugs into self-assembled nanomedicines. Nano Letters, 2014, 14:5577-5583. (IF=13.592)(Author Contributions:∥Y.W. and D.L.contributed equally to this work)10.Ma, Yan? Liu, Dan? Wang, Dun Wang, YongjunFu, Qiang Fallon, John Yang, Xingang He, Zhonggui Liu, Feng*. Combinational delivery of Hydrophobic and HydrophilicAnticancer Drugs in Single Nanoemulsions to Treat MDR in Cancer. MolecularPharmaceutics, 2014, 11, 2623-2630.(IF=4.44)(Author Contributions:∥Y.M. and D.L. contributedequally to this work)

[教育背景]
沈陽(yáng)藥科大學(xué)

添加沈陽(yáng)藥科大學(xué)學(xué)姐微信,或微信搜索公眾號(hào)“考研派小站”,關(guān)注【考研派小站】微信公眾號(hào),在考研派小站微信號(hào)輸入【沈陽(yáng)藥科大學(xué)考研分?jǐn)?shù)線、沈陽(yáng)藥科大學(xué)報(bào)錄比、沈陽(yáng)藥科大學(xué)考研群、沈陽(yáng)藥科大學(xué)學(xué)姐微信、沈陽(yáng)藥科大學(xué)考研真題、沈陽(yáng)藥科大學(xué)專業(yè)目錄、沈陽(yáng)藥科大學(xué)排名、沈陽(yáng)藥科大學(xué)保研、沈陽(yáng)藥科大學(xué)公眾號(hào)、沈陽(yáng)藥科大學(xué)研究生招生)】即可在手機(jī)上查看相對(duì)應(yīng)沈陽(yáng)藥科大學(xué)考研信息或資源。

沈陽(yáng)藥科大學(xué)考研公眾號(hào) 考研派小站公眾號(hào)

本文來(lái)源:http://m.zgxindalu.cn/syykdx/yjsds_548223.html

推薦閱讀